The Company’s Launch of Its SaliMark™ OSCC Salivary Test for Oral Cancer Includes Free CE Course, Free Industry Reception, and Free Test Kit
BROOMALL, PA–(Marketwired – Nov 21, 2014) – PeriRx, LLC, a premier developer of breakthrough, non-invasive, oral diagnostic technology, will be making its national debut at booth #1506 during the Greater New York Dental Meeting from Sunday, November 30th to Wednesday, December 3rd at the Jacob K. Javits Convention Center in New York City. [Read more…]
PeriRx LLC’s Robust Product Pipeline Includes Salivary Test for Sjogren’s Syndrome — a Common Symptom of Rheumatoid Arthritis
HAVERTOWN, PA–(Marketwired – May 28, 2014) – PeriRx LLC, a premier developer of breakthrough, non-invasive, salivary diagnostic technology, recently announced that it will be introducing a highly accurate and scientifically validated molecular biomarker test for the early detection of Sjögren’s Syndrome by the end of 2014.
Sjögren’s Syndrome is a systemic chronic inflammatory disorder in which the immune system attacks and damages the body’s moisture-producing glands. This causes dryness of the eyes and mouth and is associated with a number of oral and ocular complications. [Read more…]
The World’s Most Clinically Advanced and Scientifically Validated Molecular DNA Biomarker Test for Oral Squamous Cell Carcinoma is Launching in Late Spring
HAVERTOWN, PA–(Marketwired – Apr 3, 2014) – PeriRx LLC, a premier developer of breakthrough, non-invasive, oral diagnostic technology recently announced that it will be introducing the world’s most clinically advanced and scientifically validated molecular DNA biomarker test for oral squamous cell carcinoma detection in the late spring. [Read more…]